- Home
- ZLAB vs LOT Comparison
ZLAB vs LOT Comparison
Compare ZLAB & LOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- LOT
- Stock Information
- Founded
- ZLAB 2013
- LOT 1948
- Country
- ZLAB China
- LOT China
- Employees
- ZLAB N/A
- LOT N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- LOT
- Sector
- ZLAB Health Care
- LOT
- Exchange
- ZLAB Nasdaq
- LOT NYSE
- Market Cap
- ZLAB 3.0B
- LOT 2.5B
- IPO Year
- ZLAB 2017
- LOT N/A
- Fundamental
- Price
- ZLAB $26.05
- LOT $3.47
- Analyst Decision
- ZLAB Strong Buy
- LOT
- Analyst Count
- ZLAB 3
- LOT 0
- Target Price
- ZLAB $55.00
- LOT N/A
- AVG Volume (30 Days)
- ZLAB 482.4K
- LOT 146.2K
- Earning Date
- ZLAB 02-25-2025
- LOT 11-21-2024
- Dividend Yield
- ZLAB N/A
- LOT N/A
- EPS Growth
- ZLAB N/A
- LOT N/A
- EPS
- ZLAB N/A
- LOT N/A
- Revenue
- ZLAB $355,748,000.00
- LOT $1,013,890,000.00
- Revenue This Year
- ZLAB $49.04
- LOT $41.67
- Revenue Next Year
- ZLAB $46.70
- LOT $65.29
- P/E Ratio
- ZLAB N/A
- LOT N/A
- Revenue Growth
- ZLAB 35.01
- LOT 213.08
- 52 Week Low
- ZLAB $13.48
- LOT $3.05
- 52 Week High
- ZLAB $36.60
- LOT $17.99
- Technical
- Relative Strength Index (RSI)
- ZLAB 50.14
- LOT 44.54
- Support Level
- ZLAB $23.82
- LOT $3.05
- Resistance Level
- ZLAB $25.64
- LOT $4.09
- Average True Range (ATR)
- ZLAB 1.24
- LOT 0.36
- MACD
- ZLAB 0.06
- LOT -0.02
- Stochastic Oscillator
- ZLAB 64.45
- LOT 31.11
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About LOT LOTUS TECHNOLOGY INC
Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.